Article
CDKN1C (p57KIP2) mRNA expression in human retinoblastomas.
Ophthalmic genetics - 1 Sept 2010
Madhavan Jagadeesan, Mallikarjuna Kandalam, Vikas Khetan, George Ronnie, Bremner Rod, Kumaramanickavel Govindasamy
Abstract excerpt
PURPOSE: Quantify cyclin dependent kinase inhibitor 1C (CDKN1C or p57KIP2) mRNA levels in human retinoblastoma tumors (RB) and associate with disease phenotype. METHODS: CDKN1C mRNA expression was quantified in 55 RB, 3 retinoblastoma cell lines, and 12 control retinas by real time PCR. Localization of CDKN1C protein was confirmed by immunohistochemistry. Tumor CDKN1C expression levels were correlated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
